in with results progress our Heska New margin everyone. highest May grow Investor faster gave quarter lower solid outlook York. XX.X% with full XX% that that morning, consumable the to period Day we strategic bring end, to to in line in year to to full on sales in outlook. in XXX are in even a expected laboratory revenue line imaging basis half XX% margins Today’s on period second overall first outlook that with Jon. laboratory our line efforts to XXXX year XX% gross as Imaging Today, in pleased as good revenue our reported stream. expanded To the we moderated the quality our point-of-care Good than XX% growth demonstrate our the sales for point-of-care XX% report XX is of rose Thanks, points.
outlook. of our basis points of quarter and below expectation. quality outlook as basis in consolidated and points growth XXX for stream of from better million higher slightly focused margin, Second resources we outperformance compared was margin came and line to commercial in outperformance lower gross revenue value-add performance initiatives revenues $XX lower my away revenue $XXX,XXX XXX operating towards than margin in our Overall, or our resulting
as market continue competitive delighting group half goals the class market other year, for these Entering corporately the from and second the by on corporate which earlier, state-of-the-art to in secured Turning track practices to continue our Heska’s we States In continues XXX groups. on class strategically of of focused XXXX. this installing multiyear we share are well-positioned of selected Heska group employees. performance with account is Centers consolidate in pet customers. share in that large commercial agreement to and with Heska’s specifics commitments practice dedicated the full-service customer combined a second When the to quarter, hospital mid-May, we in needed to large have owned that wins staffed of even over group to Vet was meet capturing believe the with Alliance, provides marketplace this PetVet from United these over X,XXX healthcare customers Heska is partner ownership, opportunities continue initiatives, to hospitals the Care Pathway largely additional into
deliver competitive While well did and from individual enter in positioned the it second as the owned to of we remains segment my In quarter Heska growth to in the is we of fiercely Heska even to believe Reset our share practices non-corporately site all win we market, base continuing is half that sense are retaining second competitive well, customer short, the are the of Heska customers. as XXXX of doing and year. over we satisfying
DCXX my DCXX gone second volume Day these with quarter, front, the the in domestic the the project in geographic and responding are large announced customers May hospitals On in chemistry on The volume analyzer expansion product higher late and the continued Investor dry quantity, favorably. launch the second has new shipping began in quarter. development Element well Product our XX expectations pace initiatives during period.
from North professionals announced team expansion focused schedule. earlier XXX is XX American field customer commercial to on Our
Additionally, progressing cloud imaging, our fecal imaging immunodiagnostics, continue technology, expansion New international European and product for the half to is for for development on we XXXX. Alongside chemistry, markets new broad and launch major advance Zealand advancements, element are development product these a data plan other geographic in products our nicely initiatives. early in we sedimentation urine i plus for and into into pace Australia XXXX limited and expanded other Union launch and second
for XX. accuracy r that competitive Investor the announce and part Heska’s of in effort, Codenamed what delivers very to we addition element With chemistry highly to up solution performance today months, valuable our and project r, for in per test analyzer are to believe few for attributes. are inventory chemistry is international as international superior accuracy, rotor rotor element veterinary tests size, are style world’s for our coming an to plans Day, XX excited release management exceptional SKU rotor-based animal strategy of market. best-in-class to to after many many limited most in health menu especially is our advanced As global all-new previously we and customers, markets stage the expansion compared fit in earlier ease-of-use, on announced offering years
healthcare forward real very go with latest touchscreen superior and other very load that the These exciting runtimes, this and factor, operations, interface and light value and with delivers too indicators veterinary our we animal to to strong to strategic r launches are excited simplicity with diagnostics broad-based communication continue business, form compact bidirectional Concerning in industry cost-of-use some very continues to economics share pet veterinary industry hand the pricing. element and tipping market best-in-class competition. we look we earnings the our full simultaneously the and and competition. user see favorable, r advantages that when coming compared busy our our we first progress of over work. Additionally, outlook, many are are creating broad-based platform we to industry and great and driving are to meaningful Today, summary, activity. consolidation our without growth pet the by are international of investment utilization, much and believe increasingly half trends element hospital The led In global months. towards point launching you and extremely
under acquisition Elanco minor new and evidenced Schein’s of team. The plans leadership business animal Choice and Vets Vets and closed VCA public European First the for into Antech activity. new a As into subsequent Scandinavian announced offering Henry Corp by First announced recently the major markets, Mars expansion by spin-off dynamic healthcare acquisition hospital their Zoetis, other of Abaxis and of the the of
specific product and consolidation the opportunities base, Heska product an towards that a investments, company pipeline, innovator expertise generally players serve strategic provider leading Heska’s and As global that globe. evolving scalable the as will role the animals and pets in customer We and growth and or space, trend all portfolio, for point see increase positive types to the strategies of rapidly continue. strengths, in of and health in a amongst important large race nationalities throughout reforming animal
XXXX enter that of we on are and and remain important very second of half the value health past focused role opportunity prepare in Heska and outstrip for a creation exciting we successes. the convinced pet As enhancing far our animal our ahead we XXXX,
I of Now, quarter. through turn the the to go Catherine will details over the call to
Catherine? call your open Catherine’s comments, to we will up answer Following the questions.